A second relevant result of our systematic review and meta-analysis refers to the fact that pRb downregulation was not associated with any of the classical clinicopathological parameters with prognostic implications in oral cancer (T status, N status, clinical stage, etc.), which could indicate that alterations in this tumor suppressor essentially influence the phases of tumor initiation. Here, RB1 is linked to neoplasm.